Tag: pharmaceuticals

  • U.S. Biotech, Japanese Pharma Partner on Protein Drugs

    Anaphore Inc. of La Jolla, California and Mitsubishi Tanabe Pharma Corporation in Osaka, Japan formed a partnership for research, development, and commercialization of protein therapies for autoimmune disease. The partnership will focus on disorders such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis. The companies will make use of Anaphore’s technology, which generates novel trivalent…

  • Pfizer Stops Trials, Pulls Pulmonary Hypertension Drug

    Pfizer Inc. in New York, New York said today (10 December) that it is voluntarily withdrawing its drug Thelin (sitaxentan) for the treatment of pulmonary arterial hypertension (PAH) in the European Union, Canada, and Australia, where the drug was approved.  In addition, Pfizer is discontinuing clinical studies of Thelin worldwide. PAH is abnormally high blood pressure…

  • Pharma Mergers Jump 20 Percent in 2010 [UPDATED]

    Update: 12 January 2011. Life Science Analytics, the source of the statistics quoted in this entry, notes that the data refer to partnership deals, NOT mergers as the entry implies. The company asked that we post the following statement … Please note the reference to top deal makers in this article reflects their participation in…

  • Trial Shows Results for Multiple Myeloma Therapy

    Onyx Pharmaceuticals Inc. in Emeryville, California says that a clinical trial of its drug carfilzomib showed a sizable percentage of patients with multiple myeloma responded to treatment and for a relatively long period of time. Multiple myeloma is a cancer of the plasma cells in bone marrow. Carfilzomib is a proteasome inhibitor that blocks the…

  • Fraunhofer USA Gets FDA Go-Ahead for H5N1 Vaccine Trial

    Fraunhofer USA Center for Molecular Biotechnology (CMB) in Newark, Delaware says it received approval from the U.S. Food and Drug Administration (FDA) to proceed with the first human clinical trial of its plant-produced H5N1 influenza — avian flu — vaccine. The research institute filed an Investigational New Drug Application for its plant-derived H5N1 vaccine with…

  • Texting Service To Fight Counterfeit Malaria Drugs

    HP and African social enterprise mPedigree Network have begun a service to stop counterfeit pharmaceuticals by letting people in Nigeria and Ghana easily check the authenticity of their malaria medication. Counterfeit medicines often contain the wrong quantity of active pharmaceutical ingredients, which can result in illness or death. With the new service, patients taking a…

  • Merck To Acquire Biotech for Diabetes Treatment Technology

    Merck & Co. Inc., a global pharmaceutical manufacturer, says it will acquire SmartCells Inc., a biotechnology company in Beverly, Massachusetts developing a glucose responsive insulin formulation for the treatment of diabetes. The SmartCells process was first developed at Massachusetts Institute of Technology by its president, Todd Zion. SmartCells says its technology makes it possible to…

  • FDA Approves Two-Minute IV for Superbug Skin Complications

    Cubist Pharmaceuticals Inc. in Lexington, Massachusetts says that its currently-marketed antibiotic Cubicin (daptomycin for injection) has been approved by the U.S. Food & Drug Administration (FDA) for once-a-day dosing as a 2-minute intravenous (IV) injection. The company says Cubicin is the only approved 2-minute IV injection for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) complicated…

  • Arthritis Drug Protects Against Non-Melanoma Skin Cancer

    A widely used arthritis drug reduces the incidence of non-melanoma skin cancers according to a study published this week in the Journal of the National Cancer Institute. The COX-2 inhibitor celecoxib, approved for the treatment of osteoarthritis, rheumatoid arthritis, and acute pain in adults, led to a 62 percent reduction in non-melanoma skin cancers, which…

  • Study: Pediatric Drug Labeling Tough to Understand

    Instructions on over-the-counter (OTC) medicines for children in the U.S. are confusing and hard for parents to understand and follow, according to a study in the 1 December issue of the Journal of the American Medical Association (JAMA). Researchers at New York University’s School of Medicine, Emory University School of Medicine in Atlanta, University of…